Stocks in news: Linde India, Coal India, Vodafone Idea, InterGlobe Aviation, Bharat Forge, Cadila Healthcare, Minda Industries, KSB and more
Cadila Healthcare share hit a fresh low of Rs 355.7, falling 4.17% against the previous close of Rs 371.10 on BSE.
Pimavanserin is an atypical antipsychotic and is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
The clinical trial in Australia will study the safety, tolerability, pharmacokinetics and pharmacodynamics in patients with CAPS, Zydus Cadila said in a statement.
The CDSCO has also approved COVID-19 vaccine (ZyCoV-D) of Cadila Healthcare for restricted use in emergency situations in the age group 12 years and above.
As many as 28 companies in the index have posted growth in their bottom line.
Benchmark indices ended higher for the second consecutive session on September 5, powered by gains in index heavyweights Reliance Industries, TCS and Infosys amid a largely positive trend in global markets.
Shilpa Medicare Limited will produce the ZyCoV-D COVID-19 vaccine at its biologics R&D and manufacturing centre in Dharwad, Karnataka
Closing sharply lower, the Indian equity benchmarks Sensex and Nifty, saw a major fall as the volatility index rose 12 per cent on Monday. The fall in the market is seen in line with losses across global markets as investors wait for cues from the US Federal Reserve Bank this week
On September 17, the benchmark indices ended lower after scaling record highs as investors booked profits at higher levels. After moving in a range of 866 points during the day, Sensex closed 125.27 points lower at 59,015 and Nifty slipped 44.35 points to 17,585.
The insurance company said it acquired 6,64,104 shares of Cadila Healthcare, amounting to an additional stake of 0.065 per cent in the company.
Copyright©2025 Living Media India Limited. For reprint rights: Syndications Today